BCD Bioscience, Inc. — Form D/A
BCD Bioscience, Inc. of DAVIS, CA, a company, filed a Form D amendment with the SEC on 2020-11-12. The offering totals $4.8M, of which $4.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-11-12
- Form: D/A
- Accession: 0001813229-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $4.8M
- Investors: 15
- Date of first sale: 2020-05-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367717
Issuer
- Name: BCD Bioscience, Inc.
- CIK: 0001813229
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2019
- Address: 231 G STREET, DAVIS, CA, 95616
- Phone: (530) 400-8155
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Carlito Lebrilla | Director | Davis, CA |
| Carlito Lebrilla | Promoter | Davis, CA |
| Steven Watkins | Director | Davis, CA |
| Steven Watkins | Executive Officer | Davis, CA |
| Steven Watkins | Promoter | Davis, CA |
Other filings by this issuer (2)
More